These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 26045854)
21. Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature. Tränkenschuh W; Biesdorf AS; Papadimas N; Samara S; Hefty R; Stahl PR Int J Surg Pathol; 2019 Sep; 27(6):684-692. PubMed ID: 30955388 [TBL] [Abstract][Full Text] [Related]
22. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology? Suo L; Vega I; Thrall M J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533 [TBL] [Abstract][Full Text] [Related]
23. Carcinoma In Situ With Plasmacytoid Features: A Clinicopathologic Study of 23 Cases. Sangoi AR; Falzarano SM; Nicolas M; McKenney JK Am J Surg Pathol; 2019 Dec; 43(12):1638-1643. PubMed ID: 31368912 [TBL] [Abstract][Full Text] [Related]
24. Human epidermal growth factor receptor 2 expression in micropapillary urothelial carcinoma of the bladder: an analysis of 27 cases. Goodman AL; Osunkoya AO Hum Pathol; 2016 Nov; 57():160-164. PubMed ID: 27476777 [TBL] [Abstract][Full Text] [Related]
25. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation. Xu H; Genega EM; Zhuang L; Zhou M Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892 [TBL] [Abstract][Full Text] [Related]
26. Plasmacytoid variant of urothelial carcinoma: a report of a rare case. Demellawy DE; Ahmed AD; Bora B; Bonin M Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197 [TBL] [Abstract][Full Text] [Related]
27. Plasmacytoid urothelial carcinoma of the bladder. Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884 [TBL] [Abstract][Full Text] [Related]
28. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases. Yang Z; Epstein JI Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821 [TBL] [Abstract][Full Text] [Related]
29. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma. Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124 [TBL] [Abstract][Full Text] [Related]
30. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493 [TBL] [Abstract][Full Text] [Related]
31. CD138-positive plasmacytoid urothelial carcinoma of urinary bladder with focal micropapillary features. Demirovic A; Marusic Z; Lenicek T; Spajic B; Balicevic D; Tomas D; Kruslin B Tumori; 2010; 96(2):358-60. PubMed ID: 20572602 [TBL] [Abstract][Full Text] [Related]
32. Flat urothelial carcinoma in situ of the bladder with glandular differentiation. Lopez-Beltran A; Jimenez RE; Montironi R; Patriarca C; Blanca A; Menendez CL; Algaba F; Cheng L Hum Pathol; 2011 Nov; 42(11):1653-9. PubMed ID: 21531007 [TBL] [Abstract][Full Text] [Related]
33. Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases. Dhouib RS; Abbes I; Mrad K; Sassi S; Leila A; Driss M; Salah R; Romdhane KB Pathologica; 2005 Oct; 97(5):338-40. PubMed ID: 16480033 [TBL] [Abstract][Full Text] [Related]
34. ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma. Li J; Lu S; Lombardo K; Monahan R; Amin A Hum Pathol; 2016 Sep; 55():17-23. PubMed ID: 27137986 [TBL] [Abstract][Full Text] [Related]
35. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
36. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. Schneider SA; Sukov WR; Frank I; Boorjian SA; Costello BA; Tarrell RF; Thapa P; Houston Thompson R; Tollefson MK; Jeffrey Karnes R; Cheville JC Mod Pathol; 2014 May; 27(5):758-64. PubMed ID: 24186136 [TBL] [Abstract][Full Text] [Related]
37. "Pure" primary large cell neuroendocrine carcinoma of the urinary bladder: case report, literature review and diagnostic criteria. Pusiol T; Morichetti D; Zorzi MG Pathologica; 2014 Jun; 106(2):82-5. PubMed ID: 25291874 [TBL] [Abstract][Full Text] [Related]
38. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
39. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma. Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490 [TBL] [Abstract][Full Text] [Related]
40. p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma. Acosta AM; Barletta J; Sonpavde G; Schnitt S; Hirsch MS Arch Pathol Lab Med; 2021 Aug; 145(8):1000-1008. PubMed ID: 33237989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]